Better drugs through AI? Insitro CEO on what machine learning can teach Big Pharma ...Middle East

WASHINGTON (AP) — Artificial intelligence is changing the way companies do business — helping programmers write code and fielding customer service calls with chatbots. But the pharmaceutical industry is still waiting to see whether AI can tackle its biggest challenge: finding faster, cheaper ways to develop new drugs. Despite billions poured into research, new medicines still typically take a decade or more to develop. Founded in 2018, Insitro is part of a growing field of AI companies promising to accelerate drug discovery by using machine learning to analyze huge datasets of chemical and biological markers. The South San Francisco-based company has signed deals with drugmakers like Eli Lil

Read More Details
Finally We wish PressBee provided you with enough information of ( Better drugs through AI? Insitro CEO on what machine learning can teach Big Pharma )

Also on site :

• What to know about the trial of an ex-Michigan cop charged in the killing of a Black motorist
• Trump sees no red line that would change tariff policy - The Atlantic
• Pope Tawadros meets with mayor of Polish town